ArticleTheranostics2026

CDK9 degrader induces BRCAness and sensitizes castration-resistant prostate cancer to PARP inhibitor.

Jiaxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.